Faturação Q2 2020/2021: 19,2 M€ (-3 %)

Publicado em 27 Outubro 2020
Tópicos
Trends

Generix Group, Industrial, Logistics and Retail Ecosystems provider with leading Collaborative SaaS Solutions, issued today its revenues for the second quarter of its 2020/2021 fiscal year..

Resilient business model limits crisis impact. Q2 Revenue 2020/2021: €19.2 million (-3%

resultados generix

 
*Reclassification of €242 K for the second quarter and €482 K for the first half-year as Consulting and Services revenue, concerning services previously accounted for as Maintenance revenue. After reprocessing this reclassification, Maintenance revenue showed a slight drop (-3% for Q2 and -2% for H1), primarily as a result of the temporary suspension of contracts during the lockdown period. Consulting and Services revenue, which is by nature more vulnerable in the current context, dropped 9% over Q2 and H.

The second quarter unfolded in a continuously demanding economic and health climate. However, our customers’ confidence in our ability to support them over the long term has allowed the Group to record turnover of €19.2 M, with a decrease limited to 3%.

SaaS activities, which were slightly down, showed a drop in customary over-consumption. Contractual commitments have remained at their normal level.

License sales have grown by 30%. They were driven by a dynamic North American market, where licenses are the norm, with a threefold increase in signatures as compared to the same quarter of the previous fiscal year.

New SaaS contracts for Q2: €0.6 M

resultados generix saas

*New contracts signed expressed in ACV (Annual Contract Value), emphasize the average annual complementary revenue to be generated after implementing the contracts in question.

Our existing and prospective clients continued to sign new SaaS contracts amounting to €0.6 M, close to the amount recorded in the same quarter of the previous fiscal year.

Prospects

The level of revenue and signatures for the quarter is in line with Group expectations in the context of the pandemic. The hypothesis of a gradual return to normal economic activity starting from September 2020 has not yet materialized and leads the Group to anticipate a slight drop in revenue for the 2020/2021 fiscal year.

Work on cost structure suggests a controlled decrease in EBITDA margin, without including the impact of funding for Research and Development. This effort is part of the perspective to support expected growth in subsequent fiscal years.

With a healthy financial situation and better cash flow than this time last year, the Group confirms its strategy of consolidating activity in Europe and developing activity in North America.

 

Supplemental and non-IFRS Financial Information
Supplemental non-IFRS information (above-mentioned as EBITDA) presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Company’s supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies.
  • Next financial press release: December 7th, 2020 after the market closes
  • Results of the first half of the fiscal year 2020/2021

Aceder ao documento